CD8A and neoplasm: The study showed increased activation of dendritic cells (CD11c+MHCII+) and cytotoxic T-lymphocytes (CD8+), as well as reduced populations of regulatory T-cells (Tregs), resulting in improved tumor regression at both irradiated and distant sites.